Dachaigh › Meningioma
Sgrùdaidhean clionaigeach Meningioma a’ fastadh anns na SA
Tha 28 sgrùdaidhean airson Meningioma a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- New York City, NY8 sgrùdaidhean
- Miami, FL7 sgrùdaidhean
- Boston, MA6 sgrùdaidhean
- Columbus, OH6 sgrùdaidhean
- San Francisco, CA5 sgrùdaidhean
- San Diego, CA5 sgrùdaidhean
- Atlanta, GA5 sgrùdaidhean
- Jacksonville, FL5 sgrùdaidhean
- Houston, TX4 sgrùdaidhean
- Arlington, VA4 sgrùdaidhean
- Phoenix, AZ4 sgrùdaidhean
- Detroit, MI4 sgrùdaidhean
- St. Louis, MO3 sgrùdaidhean
- Durham, NC3 sgrùdaidhean
- Tampa, FL3 sgrùdaidhean
- Omaha, NE3 sgrùdaidhean
- Los Angeles, CA3 sgrùdaidhean
- Milwaukee, WI3 sgrùdaidhean
- Seattle, WA3 sgrùdaidhean
- Cincinnati, OH3 sgrùdaidhean
- Baltimore, MD3 sgrùdaidhean
- Cedar Rapids, IA3 sgrùdaidhean
- Nashville, TN3 sgrùdaidhean
Le stàit
- Arizona4 sgrùdaidhean
- California12 sgrùdaidhean
- Florida7 sgrùdaidhean
- Georgia5 sgrùdaidhean
- Indiana3 sgrùdaidhean
- Iowa3 sgrùdaidhean
- Kentucky3 sgrùdaidhean
- Maryland5 sgrùdaidhean
- Massachusetts6 sgrùdaidhean
- Michigan4 sgrùdaidhean
- Minnesota4 sgrùdaidhean
- Missouri3 sgrùdaidhean
- Nebraska3 sgrùdaidhean
- New Hampshire3 sgrùdaidhean
- New York9 sgrùdaidhean
- North Carolina5 sgrùdaidhean
- Ohio7 sgrùdaidhean
- Pennsylvania3 sgrùdaidhean
- Tennessee4 sgrùdaidhean
- Texas4 sgrùdaidhean
- Virginia4 sgrùdaidhean
- Washington3 sgrùdaidhean
- Wisconsin4 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06955169Natural History Study of Patients With Neurofibromatosis Type 2
A’ fastadhSgrùdadh amharc
Aoisean 8 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT00598351UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT04343157A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07428616Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
A’ fastadhÌre 2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT04374305Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06557512Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT06014905RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Lùna 2026 · NCT07150806A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT07533942Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT04427384Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
A’ fastadhÌre 1/2
Aoisean 4 gu 39 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT05278208Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
A’ fastadhÌre 1 tràth
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Ògmh 2026 · NCT07493447Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT05576103Cognitive Status After Removal of Skull Base Meningioma
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 89 · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT04635657Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT07418775Cabozantinib for Patients With Recurrent or Progressive Meningioma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT05425004Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
A’ fastadhÌre 1/2
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT05636618Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Gibl 2026 · NCT04082520Abemaciclib in Newly Diagnosed Meningioma Patients
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Màrt 2026 · NCT05940493Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
A’ fastadhÌre 4
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 27 Gearr 2026 · NCT06377371Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Gearr 2026 · NCT04278118Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Gearr 2026 · NCT06132685Evaluation of the CONVIVO System
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Gearr 2026 · NCT05139277Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Gearr 2026 · NCT06650163Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.